Showing 1 - 13 results of 13 for search 'Suzanne Lentzsch', query time: 0.84s
Refine Results
-
1
Use of daratumumab in high risk multiple myeloma: A meta‐analysis by Vikram Premkumar, Samuel Pan, Suzanne Lentzsch, Divaya Bhutani
Published 2020-07-01
Article -
2
-
3
Risk stratification models overestimate progression risk in contemporary patients with smoldering multiple myeloma by George Mellgard, Molly Gilligan, Edward R. Scheffer Cliff, Divaya Bhutani, Ghulam R. Mohyuddin, Andrew Eisenberger, Suzanne Lentzsch, Rajshekhar Chakraborty
Published 2024-03-01
Article -
4
P982: EFFICACY AND SAFETY OF 40 MG VS 60 MG OF ONCE WEEKLY SELINEXOR IN COMBINATION WITH POMALIDOMIDE AND DEXAMETHASONE IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM) by Darrell White, Muhamed Baljevic, Gary Schiller, Suzanne Lentzsch, Evgeni Chubar, Noa Lavi, Dane Van Domelen, Ohad Bentur, Sumit Madan
Published 2023-08-01
Article -
5
-
6
PB2151: CLINICAL FEATURES AND OUTCOMES OF DIFFUSE PULMONARY LIGHT CHAIN AMYLOIDOSIS: A RARE PRESENTATION OF SYSTEMIC AL AMYLOIDOSIS by Rajshekhar Chakraborty, Claudia Bellofiore, Marco Basset, Mario Nuvolone, Andrea Foli, Giampaolo Merlini, Giovanni Palladini, Mathew Maurer, Markus Mapara, Divaya Bhutani, Suzanne Lentzsch, Paolo Milani
Published 2023-08-01
Article -
7
IFN-γR/STAT1 signaling in recipient hematopoietic antigen-presenting cells suppresses graft-versus-host disease by Caisheng Lu, Huihui Ma, Liangsong Song, Hui Wang, Lily Wang, Shirong Li, Stephen M. Lagana, Antonia R. Sepulveda, Kasper Hoebe, Samuel S. Pan, Yong-Guang Yang, Suzanne Lentzsch, Markus Y. Mapara
Published 2023-02-01
Article -
8
-
9
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study by Meera Mohan, Jorge Monge, Nishi Shah, Danny Luan, Mark Forsberg, Vineel Bhatlapenumarthi, Metodi Balev, Anannya Patwari, Heloise Cheruvalath, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Samer Al-Hadidi, Dennis Cooper, Suzanne Lentzsch, Frits van Rhee, Anita D’Souza, Aniko Szabo, Carolina Schinke, Rajshekhar Chakraborty
Published 2024-03-01
Article -
10
S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA by Hans C. Lee, Naresh Bumma, Joshua Richter, Madhav Dhodapkar, James E. Hoffman, Attaya Suvannasankha, Jeffrey Zonder, Mansi R. Shah, Suzanne Lentzsch, Joseph J. Maly, Jing Christine Ye, Ka Lung Wu, Michelle Deveaux, Dhruti Chokshi, Anita Boyapati, Anasuya Hazra, Karen Rodriguez Lorenc, Glenn Kroog, Yariv Houvras, Sundar Jagannath
Published 2023-08-01
Article -
11
Gene expression profiling impacts treatment decision making in newly diagnosed multiple myeloma patients in the prospective PROMMIS trial by Noa Biran, Binod Dhakal, Suzanne Lentzsch, David Siegel, Saad Z. Usmani, Adriana Rossi, Cara Rosenbaum, Divaya Bhutani, David H. Vesole, Cesar Rodriguez, Ajay K. Nooka, Frits vanRhee, Lisette Stork‐Sloots, Femke deSnoo, Pritish K. Bhattacharyya, Durga Prasad Dash, Sena Zümrütçü, Martin H. vanVliet, Parameswaran Hari, Ruben Niesvizky
Published 2021-08-01
Article -
12
Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma by Cristina Gasparetto, Suzanne Lentzsch, Gary Schiller, Natalie Callander, Sascha Tuchman, Christine Chen, Darrell White, Rami Kotb, Heather Sutherland, Michael Sebag, Muhamed Baljevic, William Bensinger, Richard LeBlanc, Chris Venner, Nizar Bahlis, Adriana Rossi, Noa Biran, Heidi Sheehan, Jean‐Richard Saint‐Martin, Dane Van Domelen, Kazuharu Kai, Jatin Shah, Sharon Shacham, Michael Kauffman, Brea Lipe
Published 2021-02-01
Article -
13
Selinexor‐based regimens in patients with multiple myeloma after prior anti‐B‐cell maturation antigen treatment by Muhamed Baljevic, Cristina Gasparetto, Gary J. Schiller, Sascha A. Tuchman, Natalie S. Callander, Suzanne Lentzsch, Jorge Monge, Rami Kotb, Nizar J. Bahlis, Darrell White, Christine I. Chen, Heather J. Sutherland, Sumit Madan, Richard LeBlanc, Michael Sebag, Christopher P. Venner, William I. Bensinger, Noa Biran, Andrew DeCastro, Dane R. Van Domelen, Chris Zhang, Jatin J. Shah, Sharon Shacham, Michael G. Kauffman, Ohad S. Bentur, Brea Lipe
Published 2022-11-01
Article